Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Strangfeld

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
RMD Open|October 14, 2020
Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBITMartin Schäfer, Katinka Albrecht, Jörn Kekow, et al.
Arthritis Care & Research|March 26, 2014
Sustainability of rituximab therapy in different treatment strategies: results of a 3-year followup of a German biologics registerAdrian Richter, Anja Strangfeld, Peter Herzer, et al.
RMD Open|October 18, 2020
Incidence of facial nerve palsies stratified by DMARD treatment in patients with rheumatoid arthritis: data from the RABBIT registerYvette Meissner, Martin Schäfer, Matthias Schneider, et al.
Arthritis Research & Therapy|June 25, 2016
Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databasesKatinka Albrecht, Adrian Richter, Johanna Callhoff, et al.
Annals of the Rheumatic Diseases|December 3, 2013
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximabJoachim Listing, Jörn Kekow, Bernhard Manger, et al.
RMD Open|July 23, 2024
No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registryAnne Constanze Regierer, David Kiefer, Georg Schett, et al.
Rheumatology and Therapy|January 8, 2025
Real-World Prevalence, Incidence and Management of Systemic Lupus Erythematosus in Germany: A Retrospective Claims Data AnalysisTobias Alexander, Philipp Sewerin, Anja Strangfeld, et al.
Seminars in Arthritis and Rheumatism|October 15, 2018
Are prognostic factors adequately selected to guide treatment decisions in patients with rheumatoid arthritis? A collaborative analysis from three observational cohortsLisa Baganz, Adrian Richter, Katinka Albrecht, et al.
Arthritis Research & Therapy|August 27, 2024
Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinibMerete Lund Hetland, Anja Strangfeld, Gianluca Bonfanti, et al.
RMD Open|October 25, 2023
Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT registerYvette Meissner, Martin Schäfer, Katinka Albrecht, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
RMD Open|October 14, 2020
Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBITMartin Schäfer, Katinka Albrecht, Jörn Kekow, et al.
Arthritis Care & Research|March 26, 2014
Sustainability of rituximab therapy in different treatment strategies: results of a 3-year followup of a German biologics registerAdrian Richter, Anja Strangfeld, Peter Herzer, et al.
RMD Open|October 18, 2020
Incidence of facial nerve palsies stratified by DMARD treatment in patients with rheumatoid arthritis: data from the RABBIT registerYvette Meissner, Martin Schäfer, Matthias Schneider, et al.
Arthritis Research & Therapy|June 25, 2016
Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databasesKatinka Albrecht, Adrian Richter, Johanna Callhoff, et al.
Annals of the Rheumatic Diseases|December 3, 2013
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximabJoachim Listing, Jörn Kekow, Bernhard Manger, et al.
RMD Open|July 23, 2024
No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registryAnne Constanze Regierer, David Kiefer, Georg Schett, et al.
Rheumatology and Therapy|January 8, 2025
Real-World Prevalence, Incidence and Management of Systemic Lupus Erythematosus in Germany: A Retrospective Claims Data AnalysisTobias Alexander, Philipp Sewerin, Anja Strangfeld, et al.
Seminars in Arthritis and Rheumatism|October 15, 2018
Are prognostic factors adequately selected to guide treatment decisions in patients with rheumatoid arthritis? A collaborative analysis from three observational cohortsLisa Baganz, Adrian Richter, Katinka Albrecht, et al.
Arthritis Research & Therapy|August 27, 2024
Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinibMerete Lund Hetland, Anja Strangfeld, Gianluca Bonfanti, et al.
RMD Open|October 25, 2023
Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT registerYvette Meissner, Martin Schäfer, Katinka Albrecht, et al.
Pageof 13